How much does Ozempic cost: $25 covered, $199 to $499 cash, and why the weight-loss version of the same drug is cheaper

Ozempic's price depends on one question before any other: are you buying it for diabetes or for weight? For diabetes it is one of the best-covered drugs in the country and $25 a month is realistic. For weight it is uncovered, off-label, and more expensive than the identical molecule in a different box. Here are all four prices and which one you will get.

Price 1: covered by a commercial plan, $25

Ozempic is approved for adults with type 2 diabetes: to improve blood sugar, to reduce cardiovascular events in those with established heart disease, and to slow kidney decline in those with chronic kidney disease.³ Plans cover it for those uses, usually after prior authorisation, and the criteria are typically about metformin. Aetna, for instance, grants it "for a diagnosis of type 2 diabetes mellitus" where "the patient has experienced an inadequate treatment response, intolerance, or has a contraindication to metformin".⁵

Once covered, Novo's card applies: "Pay as little as $25 for any dose of Ozempic pen for up to a 3-month prescription", "subject to a maximum savings of $100/month".¹ The cap matters. If your copay is $150, the card takes it to $50, not $25. The card does not run forever, but it runs long: Novo says it "is valid for up to 48 months".¹ So a diabetic on a covered plan can budget about four years at the card price before the terms need a fresh look.

Government plans are excluded: "Medicare beneficiaries with Part D coverage are not eligible for the Ozempic pay as little as $25 offer".¹ Part D commonly covers Ozempic for diabetes at its own copay, and Novo adds that Part D members "are also eligible for self-pay options",¹ which matters if your plan's copay is higher than Novo's cash price. The Ozempic coupon guide works through the card's arithmetic.

Price 2: cash, the pen, $199 then $349 or $499

Novo sells Ozempic direct to uninsured and self-pay patients through NovoCare Pharmacy, and prices it by dose:¹²

The label's ladder is 0.25 mg for four weeks, then 0.5 mg, then 1 mg and 2 mg "if additional glycemic control is needed", each after at least four weeks on the dose below.³ So the $199 covers the two starting months exactly, and the price you live at is $349, or $499 if you end up at 2 mg. Novo's "month" is one pen,² and a 1 mg or 2 mg pen holds four weekly doses,³ so a year of weekly shots takes 13 pens, not 12. A first year at 1 mg is 2 × $199 plus 11 × $349, or $4,237, and each year after is 13 × $349, or $4,537. A first year that reaches 2 mg as fast as the label allows (one pen at 1 mg, then 2 mg) is 2 × $199 + $349 + 10 × $499, or $5,737, and each year after is 13 × $499, or $6,487.

Price 3: cash, the pill, from $149

There is now an Ozempic tablet, and Novo lists it at "starting at $149 per month".² That is the entry strength. Novo prices the pill by strength, and a "month" is one bottle of 30 tablets:¹²

Even the top strength sits below the $349 pen price, so the tablet is the cheapest branded Ozempic at every step Novo lists. The strength you end up on is your prescriber's call, not a price choice. For anyone paying cash who does not want a weekly injection, it is the first thing to ask about. The GLP-1 pill guide covers what the oral forms give up against the pens.

Price 4: for weight loss, and why it is the wrong purchase

None of the three indications on Ozempic's label is weight.³ Prescribers write it off-label for weight all the time, but no insurer covers it for that. A weight-loss Ozempic prescription is a cash prescription at the prices above. Here is where eight insurers stand, in their own documents:

And here is the thing that makes weight-loss Ozempic a poor buy even in cash: Wegovy is the same semaglutide, approved for weight, from the same company, and it is cheaper. Novo's own pharmacy prices the Wegovy pen at $349 at every dose including 2.4 mg, against Ozempic's $499 at 2 mg, and the Wegovy tablet at $149 to $299.⁴ The $199 two-fill introductory offer applies to both.²⁴ So for weight, at cash, the Wegovy box costs the same or less at every rung. It can also be covered by a plan that has a weight benefit, which Ozempic never will be. Wegovy vs Ozempic sets out the box difference in full.

Price 5: compounded semaglutide, from $69

The cheapest semaglutide is not Novo's at all. Compounded semaglutide, the same molecule from a licensed pharmacy without FDA approval of the finished product, is sold through telehealth programs at prices verified on each seller's page today:

What the gap to Novo's price buys, and what FDA specifically worries about, is in is compounded semaglutide safe.

All five, side by side

One catch with every cash price: it sits outside your insurance

Novo states it plainly: "If you use a self-pay offer, your prescription is purchased outside of your insurance plan, and you cannot ask your insurance to reimburse you or count the cost of this medicine toward your insurance deductible or out-of-pocket limit."¹ Two consequences follow. A year of cash Ozempic does nothing toward meeting a high deductible, so someone close to their out-of-pocket maximum may pay less through the plan. And a cash month cannot be claimed back later if a prior authorisation comes through. Ask for the authorisation first when there is a real chance of it, and pay cash while you wait only if the gap is short.

The honest summary

For type 2 diabetes, Ozempic is a $25 drug for most people with a commercial plan and a covered drug on Medicare. For weight, it is a $349 to $499 cash drug that the same company sells for less under the name Wegovy, and that a licensed pharmacy compounds for $69. Decide which of those you are before you decide what Ozempic costs, because the answer is different by a factor of twenty.